The effect of thymidine on the antibacterial and antiviral activity of zidovudine.
The effect of thymidine and deoxyadenosine on the antiviral and antibacterial effect of zidovudine was studied in human immunodeficiency virus type 1 (HIV-1) Escherichia coli and Salmonella typhimurium. In quantitative assays, 10 micrograms mL-1 thymidine was shown to increase the 50% inhibitory concentration (IC50) of zidovudine for HIV-1 by approximately 100-fold and to reduce zidovudine (1 microM)-induced protection of C8166 cells from 2.04 to 0.18 log syncytial-forming units. Thymidine also antagonized the antibacterial effect of zidovudine for two E. coli and three S. typhimurium species in a dose-dependent manner; 10 micrograms mL-1 of thymidine increased the minimum inhibitory concentration of zidovudine for E. coli strains by 10-40-fold and for S. typhimurium strains by three-fold. Deoxyadenosine reduced the minimum inhibitory concentration of zidovudine against all five bacterial strains but had no effect on the IC50 of zidovudine for HIV-1, nor did it significantly reverse the antagonism of the antibacterial and antiviral activity of thymidine. The induction of the SOS response in E. coli was reversed in a dose-dependent manner by thymidine while the presence of deoxyadenosine increased induction of the SOS response by zidovudine at suboptimal concentrations.
Department of Medical Microbiology, University of Edinburgh, UK.
A J
AJ
Shepherd
P
P
Barr
C S
CS
Lewin
D003839:Deoxyadenosines / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D015497:HIV-1 / Q000187:drug effects; D013014:SOS Response, Genetics / Q000187:drug effects; D012486:Salmonella typhimurium / Q000187:drug effects; D013936:Thymidine / Q000494:pharmacology*; D015215:Zidovudine / Q000494:pharmacology*
D003839:Deoxyadenosines; D015215:Zidovudine; D013936:Thymidine